Skip to main content
Clinical Trials/NCT02167386
NCT02167386CompletedPhase 4

PrEP for Black MSM: Community-Based Ethnography and Clinic-Based Treatment

Columbia University2 sites in 1 country204 target enrollmentStarted: March 30, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
204
Locations
2
Primary Endpoint
adherence to daily Truvada use

Study Overview

Brief Summary

Black men who have sex with men (MSM) have among the highest rates of new HIV infections of any group in the United States. Developing effective HIV prevention interventions that work with this group is a critical element of the National HIV/AIDS Strategy. In the first phase of our study ("the ethnographic phase"), the investigators will carry out community-based research that will explore structural, social and cultural factors relevant to how Black MSM might engage with Pre-Exposure Prophylaxis (PrEP). This phase of community-based research will inform the design of an enhanced PrEP adherence intervention, which will be subsequently tested at a community-based health clinic in Harlem in the second phase of the project.

Detailed Description

STUDY OBJECTIVES AND DESIGN This randomized clinical trial will enroll HIV-uninfected Black MSM and transgender females (TGF) and randomly assign them to receive enhanced versus standard PrEP adherence packages. Study participants will receive PrEP-related clinical care at Harlem United, a community-based healthcare provider in New York City's Central Harlem.

Primary Objective Compare the effectiveness of enhanced versus standard packages for increasing adherence to PrEP in a community-based primary care clinic

Secondary Objectives

  1. Compare the enhanced and standard PrEP adherence packages on:
  • sexual risk behaviors
  • retention in care
  • PrEP knowledge
  • seroconversions
  1. Examine the safety of PrEP among participants as measured by the type and frequency of adverse events
  2. Describe acceptability of daily PrEP among Black MSM and TGF generally and among those who have agreed to take PrEP

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • male at birth
  • self-identify as Black, African American, Caribbean Black, African, or multiethnic Black
  • are 18 years of age or older
  • any male or transgender woman (TGW) partners in past 6 months;
  • not in a monogamous partnership with a recently tested, HIV-negative man;
  • have at least one of the following:
  • reporting condomless anal and/or receptive neovaginal intercourse with at least one man or TGW in the past six months;
  • any STI diagnosed or reported in past 6 months;
  • is in on-going sexual relationship with an HIV-positive male or TGW partner;
  • able to provide written informed consent in English;
  • able to provide a street address or residence or phone number for themselves or two personal contacts who would know their whereabouts during participation in the study

Exclusion Criteria

  • current participation in any other PrEP study;
  • having taken PrEP in programmatic context more than 3 months

Arms & Interventions

Enhanced PrEP Adherence

Experimental

Enhanced PrEP Adherence: peer navigators, PrEP support group, on-line support group, text message reminders

Intervention: Enhanced PrEP Adherence (Behavioral)

Standard PrEP Adherence

Active Comparator

Standard PrEP Adherence: support groups, case management

Intervention: Standard PrEP Adherence (Behavioral)

Outcomes

Primary Outcomes

adherence to daily Truvada use

Time Frame: twelve months after enrollment

this is a measure of PrEP adherence, to be implemented through self-reported adherence and collection of dried blood spots

Secondary Outcomes

  • number of participants remaining in care(end of 12-month study period)
  • percentage of sexual acts where condom was used(twelve months after enrollment)
  • number of correct knowledge items(twelve months after enrollment)
  • positive HIV test(during 12-month study period)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Paul Colson

Associate Research Scientist

Columbia University

Study Sites (2)

Loading locations...

Similar Trials